Tag: LAAC
AHA 2024: OPTION trial reports positive outcomes for Watchman FLX at...
Three-year results from the OPTION clinical trial, comparing the Watchman FLX (Boston Scientific) left atrial appendage closure (LAAC) system to oral anticoagulation for stroke...
GLACE study to assess ICE imaging during LAA closure
Conformal Medical has announced the initiation of the GLACE Study, assessing the use of intracardiac echocardiography (ICE) imaging of the left atrial appendage (LAA)...
CRT 2022: SURPASS registry shows low rate of adverse events associated...
Results from a new analysis assessing real-world outcomes with the Watchman FLX (Boston Scientific) left atrial appendage closure (LAAC) demonstrated a low rate of...
Left atrial appendage closure associated with a decreased stroke risk in...
Left atrial appendage closure (LAAC) via implanted device was associated with a decreased risk of admission for stroke, compared with the expected risk without...
ESC 2019: Left atrial appendage closure is non-inferior to NOACS for...
At the 2019 European Society of Cardiology (ESC) Congress (31 August–4 September, Paris, France), Pavel Osmancik (Charles University and University Hospital Kralovske Vinohrady, Prague,...
Vivek Reddy on the final outcomes of PREVAIL and PROTECT-AF
Boston Scientific has announced the final five-year outcomes data from the PREVAIL study during a late-breaking clinical trial session at this year’s Transcatheter Cardiovascular...